Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Curing acute lymphoblastic leukemia and avoiding osteonecrosis: can't we have it all?

Ducassou S, Pérel Y.

Pediatr Blood Cancer. 2013 May;60(5):713-4. doi: 10.1002/pbc.24388. Epub 2013 Jan 17. No abstract available.

PMID:
23335158
2.

Effectiveness of pamidronate as treatment of symptomatic osteonecrosis occurring in children treated for acute lymphoblastic leukemia.

Leblicq C, Laverdière C, Décarie JC, Delisle JF, Isler MH, Moghrabi A, Chabot G, Alos N.

Pediatr Blood Cancer. 2013 May;60(5):741-7. doi: 10.1002/pbc.24313. Epub 2012 Sep 21.

PMID:
23002054
3.

Pharmacological treatment of osteonecrosis.

Aspenberg P.

Acta Orthop. 2006 Apr;77(2):175-6. No abstract available.

PMID:
16752277
4.
5.

Osteonekrose: Schützt Zoledronsäure vor Kollaps des Femurkopfs?

Rotter R.

Z Orthop Unfall. 2015 Oct;153(5):471. German. No abstract available.

PMID:
26740976
6.

Incidence and outcome of osteonecrosis in children and adolescents after intensive therapy for acute lymphoblastic leukemia (ALL).

Padhye B, Dalla-Pozza L, Little D, Munns C.

Cancer Med. 2016 May;5(5):960-7. doi: 10.1002/cam4.645. Epub 2016 Jan 20.

7.

Use of bisphosphonates for the treatment of osteonecrosis as a complication of therapy for childhood acute lymphoblastic leukaemia (ALL).

Kotecha RS, Powers N, Lee SJ, Murray KJ, Carter T, Cole C.

Pediatr Blood Cancer. 2010 Jul 1;54(7):934-40. doi: 10.1002/pbc.22428.

PMID:
20127847
8.
9.

Avascular necrosis of bone in leukemia and osteonecrosis of jaw by bisphosphonates.

Nastro E, Allegra A, Oteri G, Ferlito S, Alonci A, Bellomo G, D'Angelo A, Tolomeo A, Cicciù D, De Ponte FS, Musolino C.

J Oral Maxillofac Surg. 2009 Dec;67(12):2701-3. doi: 10.1016/j.joms.2008.05.369. No abstract available.

PMID:
19926001
10.

Bisphosphonate therapy for reduced bone mineral density during treatment of acute lymphoblastic leukemia in childhood and adolescence: a report of preliminary experience.

Lethaby C, Wiernikowski J, Sala A, Naronha M, Webber C, Barr RD.

J Pediatr Hematol Oncol. 2007 Sep;29(9):613-6.

PMID:
17805035
11.

[Osteonecrosis of the jaw following complex tumour treatment using bisphosphonates].

Machálka M.

Vnitr Lek. 2006 Nov;52 Suppl 2:79, 81-2. Czech.

PMID:
18181284
12.

Managing the adverse effects of bisphosphonate therapy on the jaw.

Rizzolo D, Sedrak M.

JAAPA. 2009 Nov;22(11):48-52. No abstract available.

PMID:
19999176
13.

Case 2. Osteonecrosis of the jaws associated with bisphosphonate therapy.

Mignogna MD, Fedele S, Lo Russo L, Ciccarelli R, Lo Muzio L.

J Clin Oncol. 2006 Mar 20;24(9):1475-7. No abstract available. Erratum in: J Clin Oncol. 2006 Jun 10;24(17):2687.

PMID:
16549843
14.

Complication related to bisphosphonate therapy: osteonecrosis of the jaw.

Lee J.

J Infus Nurs. 2009 Nov-Dec;32(6):330-5. doi: 10.1097/NAN.0b013e3181bd5373.

PMID:
19918142
15.

[Bisphosphonates-associated osteonecrosis of the jaw: review on reported cases].

Gering A, Grange L, Villier C, Woeller A, Mallaret M.

Therapie. 2007 Jan-Feb;62(1):49-54. Epub 2007 Mar 21. French.

PMID:
17374348
16.

Childhood aleukemic leukemia with hypercalcemia and bone lesions mimicking metabolic bone disease.

Ganesan P, Thulkar S, Gupta R, Bakhshi S.

J Pediatr Endocrinol Metab. 2009 May;22(5):463-7.

PMID:
19618667
17.

Bisphosphonates and osteonecrosis: potential treatment or serious complication?

Goytia RN, Salama A, Khanuja HS.

Orthop Clin North Am. 2009 Apr;40(2):223-34. doi: 10.1016/j.ocl.2008.12.002. Review.

PMID:
19358907
18.

Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients.

Walter C, Al-Nawas B, Frickhofen N, Gamm H, Beck J, Reinsch L, Blum C, Grötz KA, Wagner W.

Head Face Med. 2010 Jul 8;6:11. doi: 10.1186/1746-160X-6-11.

19.

Osteonecrosis of the jaw (ONJ) risk in breast cancer patients after zoledronic acid treatment.

Fusco V, Loidoris A, Colella G, Vescovi P, Campisi G.

Breast. 2010 Oct;19(5):432-3; author reply 433-4. doi: 10.1016/j.breast.2010.03.008. Epub 2010 Apr 2. No abstract available.

PMID:
20363135
20.

Treating osteoporosis: do bisphosphonates really increase the risk of osteonecrosis of the jaw?

Thompson E, Sheehy C, Barry M, Carey J.

Ir Med J. 2008 Jun;101(6):166-7. No abstract available.

PMID:
18700507

Supplemental Content

Support Center